-transparent.png){kind=logo}
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "miR-181a down-regulates MAP2K1 to enhance adriamycin sensitivity in leukemia HL-60 cells, by J.-J. Wang, J.-P. Yu, published in Eur Rev Med Pharmacol Sci 2019; 23 (6): 2497-2504-DOI: 10.26355/eurrev_201903_17397-PMID: 30964176" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/17397.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
J-J Wang, and
J-P Yu
April 2012,
Journal of cancer research and clinical oncology,
J-J Wang, and
J-P Yu
January 1990,
Biochemical and biophysical research communications,
J-J Wang, and
J-P Yu
October 2002,
Ai zheng = Aizheng = Chinese journal of cancer,
J-J Wang, and
J-P Yu
January 2021,
Current gene therapy,
J-J Wang, and
J-P Yu
July 2007,
Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology,
J-J Wang, and
J-P Yu
February 2008,
Biochemical pharmacology,
J-J Wang, and
J-P Yu
November 1998,
Zhongguo yao li xue bao = Acta pharmacologica Sinica,
J-J Wang, and
J-P Yu
October 2020,
Molecular medicine reports,
J-J Wang, and
J-P Yu
August 2010,
Chemical & pharmaceutical bulletin,
J-J Wang, and
J-P Yu
September 2020,
European review for medical and pharmacological sciences,
